Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.

Publication ,  Journal Article
Stockerl-Goldstein, KE; Reddy, SA; Horning, SF; Blume, KG; Chao, NF; Hu, WW; Johnston, LF; Long, GD; Strober, S; Wong, RM; Feiner, RH ...
Published in: Biol Blood Marrow Transplant
2000

Our purpose was to evaluate the outcome and costs of high-dose chemotherapy and autologous peripheral blood progenitor cell (PBPC) transplantation in patients with the inability to mobilize sufficient numbers of PBPCs to allow rapid engraftment after PBPC transplantation. We treated 172 consecutive non-Hodgkin's lymphoma (NHL) patients with cyclophosphamide and granulocyte colony-stimulating factor followed by apheresis to collect PBPCs. The cells were separated on a Percoll gradient and purged with monoclonal antibodies and complement. The patients were categorized as "good" mobilizers if a collection of > or =2 x 10(6) CD34+ cells/kg was obtained (n = 138, 80%) or "poor" mobilizers if <2 x 10(6) CD34+ cells/kg were obtained (n = 34, 20%). With a median follow-up of 3.5 years, there is no statistically significant difference in actuarial event-free survival, overall survival, or relapse for good mobilizers compared with poor mobilizers. However, there was a trend toward increasing nonrelapse, transplantation-related mortality of 11.8% for poor mobilizers versus 3.6% for good mobilizers (P = .08) and early death from all causes including relapse within 120 days (poor 20.6% versus good 8.7%, P = .06). The total cost for bone marrow transplantation-related care was significantly higher, at $140,264 for poor mobilizers versus $80,833 for good mobilizers (P = .0001). The population of patients with NHL who mobilize PBPCs poorly into the circulation have a higher cost for posttransplant support. However, there is no significant difference in relapse, event-free survival, or overall survival for such patients compared with those who mobilize PBPCs easily.

Duke Scholars

Published In

Biol Blood Marrow Transplant

DOI

ISSN

1083-8791

Publication Date

2000

Volume

6

Issue

5

Start / End Page

506 / 512

Location

United States

Related Subject Headings

  • Whole-Body Irradiation
  • Treatment Outcome
  • Remission Induction
  • Middle Aged
  • Male
  • Lymphoma, Non-Hodgkin
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Mobilization
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stockerl-Goldstein, K. E., Reddy, S. A., Horning, S. F., Blume, K. G., Chao, N. F., Hu, W. W., … Negrin, R. S. (2000). Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant, 6(5), 506–512. https://doi.org/10.1016/s1083-8791(00)70021-8
Stockerl-Goldstein, K. E., S. A. Reddy, S. F. Horning, K. G. Blume, N. F. Chao, W. W. Hu, L. F. Johnston, et al. “Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.Biol Blood Marrow Transplant 6, no. 5 (2000): 506–12. https://doi.org/10.1016/s1083-8791(00)70021-8.
Stockerl-Goldstein KE, Reddy SA, Horning SF, Blume KG, Chao NF, Hu WW, et al. Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant. 2000;6(5):506–12.
Stockerl-Goldstein, K. E., et al. “Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.Biol Blood Marrow Transplant, vol. 6, no. 5, 2000, pp. 506–12. Pubmed, doi:10.1016/s1083-8791(00)70021-8.
Stockerl-Goldstein KE, Reddy SA, Horning SF, Blume KG, Chao NF, Hu WW, Johnston LF, Long GD, Strober S, Wong RM, Feiner RH, Kobler S, Negrin RS. Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. Biol Blood Marrow Transplant. 2000;6(5):506–512.
Journal cover image

Published In

Biol Blood Marrow Transplant

DOI

ISSN

1083-8791

Publication Date

2000

Volume

6

Issue

5

Start / End Page

506 / 512

Location

United States

Related Subject Headings

  • Whole-Body Irradiation
  • Treatment Outcome
  • Remission Induction
  • Middle Aged
  • Male
  • Lymphoma, Non-Hodgkin
  • Immunology
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Mobilization